The viral envelope in the evolution of HIV: A hypothetical approach to inducing an effective immune response to the virus

Medical Hypotheses

Volumn 48, Issue 6, 1997, Pages 517-521

  Ngu, V A ^a  

^a Faculty of Medicine and Biomedical Sciences   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOREGULATION; IMMUNOTHERAPY; INFECTION RISK; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; VIRUS ENVELOPE; VIRUS INFECTIVITY;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0030877554     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(97)90122-5     Document Type: Article

References (18)

1. Barré-Sinoussi F, Charmann J C, Rey F et al. Isolation of a T-lymphotropic retrovirus from a patient at high risk for acquired immune deficiency syndrome AIDS. Science 1983; 220: 868-871.
2. Lifson A R, Buchbinder S P, Sheppard H W et al. Long-term human immunodeficiency virus infection in asymptomatic homosexual and bisexual men with normal CD4+ lymphocyte count: immunologic and virologic characteristics. J Infect Dis 1991; 163: 959-965.
3. Benn S, Rutledge R, Folks T et al. Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire. Science 1985; 230: 949-951.
4. Alizon M, Sonigo P, Barré-Sinoussi F et al. Molecular cloning of lymph adenopathy associated virus. Nature 1984; 312: 757-760.
5. McKeating J A, Gow J, Goudsmit J et al. Characterization of HIV 1 neutralization escape mutants. AIDS 1989; 3: 777-784.
6. Barré-Sinoussi F. Succès et desarrois des sciences de la vie face au virus du Sida. Annals de l'Institut Pasteur. Actualités 1994; 5 (1): 3-18.
7. Ngu V A. Chronic infections from the perspective of evolution: a hypothesis. Med Hypotheses 1994; 42: 81-88.
8. McKeating J A, Willey R L. Structure and function of the HIV envelope. AIDS 1989; 3: S35-S41.
9. Bergeron L, Sullivan N, Sodroski J. Target cell-specific determinants of membrane fusion within the human immunodeficiency virus type 1 GP120 third variable region and GP41 amino terminus. J Virol 1992; 66: 2389-2397.
10. Zeigler J L, Stites D P. Hypothesis: AIDS is an auto-immune disease directed at the immune system and triggered by a lymphotropic retrovirus. Clin Immunol Immunopathol 1986; 41: 305-313.
11. Retroviridae. In: Andrewes C H, Pereira H G, Wildy P, eds. Viruses of Vertebrates. 4th edn. London: Baillière Tindall 1978: 133-165.
12. Autran B, Levine N L. HIV epitopes recognized by cytotoxic T-lymphocytes. AIDS 1991; 5(Suppl. 2): S145-S150.
13. Gallo R C, Wong-Staal F. Retroviruses as aetiological agents of some animal and human leukemias and lymphomas and as a tool for elucidating the molecular mechanism of leukemogenesis. Blood 1982; 60 (3): 545-557.
14. Charmann H P, Blades S, Gilden R V et al. EIA: Evidence favoring classification as a retrovirus. J Virol 1976; 19: 1079.
15. Crawford T B, Adams D S, Cheevers W P et al. Chronic arthritis in goats caused by a retrovirus. Science 1980; 207: 997-999.
16. Gibbons R A, Hunter G D. Nature of scrapie agent. Nature 1967; 215: 1041-1045.
17. Epstein M A, Achong B G, Barr Y M. Virus particles in cultured lymphoblasts from Burkitts lymphoma. Lancet 1964; i: 702-703.
18. Geraldo G, Beth E, Henle W et al. Antibody patterns to herpes viruses in Kaposis sarcoma. II: Serological association of American Kaposis sarcoma with cytomegalovirus. Int J Cancer 1978; 22 (2): 126-131.